{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:31:34Z","timestamp":1784867494067,"version":"3.55.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00228-023-03573-6","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:03:21Z","timestamp":1696334601000},"page":"1595-1606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and risk factors of drug-induced kidney injury in children: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"79","author":[{"given":"Miao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchen","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"9843","key":"3573_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/s0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo R, Kellum JA, Ronco C (2012) Acute kidney injury. Lancet 380(9843):756\u2013766. https:\/\/doi.org\/10.1016\/s0140-6736(11)61454-2","journal-title":"Lancet"},{"issue":"1","key":"3573_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1611391","volume":"376","author":"A Kaddourah","year":"2017","unstructured":"Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL (2017) Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 376(1):11\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1611391","journal-title":"N Engl J Med"},{"issue":"9","key":"3573_CR3","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.2215\/cjn.02140215","volume":"10","author":"X Xu","year":"2015","unstructured":"Xu X, Nie S, Liu Z et al (2015) Epidemiology and clinical correlates of AKI in Chinese hospitalized adults. Clin J Am Soc Nephrol 10(9):1510\u20131518. https:\/\/doi.org\/10.2215\/cjn.02140215","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3573_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2215\/cjn.02730313","volume":"9","author":"X Zeng","year":"2014","unstructured":"Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS (2014) Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 9(1):12\u201320. https:\/\/doi.org\/10.2215\/cjn.02730313","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"3573_CR5","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2215\/cjn.00710113","volume":"8","author":"P Susantitaphong","year":"2013","unstructured":"Susantitaphong P, Cruz DN, Cerda J et al (2013) World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol 8(9):1482\u20131493. https:\/\/doi.org\/10.2215\/cjn.00710113","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9887","key":"3573_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/s0140-6736(13)60439-0","volume":"382","author":"KU Eckardt","year":"2013","unstructured":"Eckardt KU, Coresh J, Devuyst O et al (2013) Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382(9887):158\u2013169. https:\/\/doi.org\/10.1016\/s0140-6736(13)60439-0","journal-title":"Lancet"},{"issue":"4","key":"3573_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/bcp.12554","volume":"80","author":"LN Faught","year":"2015","unstructured":"Faught LN, Greff MJ, Rieder MJ, Koren G (2015) Drug-induced acute kidney injury in children. Br J Clin Pharmacol 80(4):901\u2013909. https:\/\/doi.org\/10.1111\/bcp.12554","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3573_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00467-005-2105-4","volume":"21","author":"N Chen","year":"2006","unstructured":"Chen N, Aleksa K, Woodland C, Rieder M, Koren G (2006) Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 21(2):160\u2013168. https:\/\/doi.org\/10.1007\/s00467-005-2105-4","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"3573_CR9","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41(8):1411\u20131423. https:\/\/doi.org\/10.1007\/s00134-015-3934-7","journal-title":"Intensive Care Med"},{"issue":"4","key":"3573_CR10","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","volume":"66","author":"RL Mehta","year":"2004","unstructured":"Mehta RL, Pascual MT, Soroko S et al (2004) Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 66(4):1613\u20131621. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00927.x","journal-title":"Kidney Int"},{"issue":"6","key":"3573_CR11","first-page":"743","volume":"78","author":"CA Naughton","year":"2008","unstructured":"Naughton CA (2008) Drug-induced nephrotoxicity. Am Fam Physician 78(6):743\u2013750","journal-title":"Am Fam Physician"},{"issue":"7","key":"3573_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.294.7.813","volume":"294","author":"S Uchino","year":"2005","unstructured":"Uchino S, Kellum JA, Bellomo R et al (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294(7):813\u2013818. https:\/\/doi.org\/10.1001\/jama.294.7.813","journal-title":"JAMA"},{"issue":"6 Suppl","key":"3573_CR13","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1097\/CCM.0b013e3181de0c60","volume":"38","author":"ML Bentley","year":"2010","unstructured":"Bentley ML, Corwin HL, Dasta J (2010) Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies. Crit Care Med 38(6 Suppl):S169\u2013S174. https:\/\/doi.org\/10.1097\/CCM.0b013e3181de0c60","journal-title":"Crit Care Med"},{"issue":"12","key":"3573_CR14","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00467-007-0721-x","volume":"23","author":"L Patzer","year":"2008","unstructured":"Patzer L (2008) Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 23(12):2159\u20132173. https:\/\/doi.org\/10.1007\/s00467-007-0721-x","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3573_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.2015.115","volume":"88","author":"RL Mehta","year":"2015","unstructured":"Mehta RL, Awdishu L, Davenport A et al (2015) Phenotype standardization for drug-induced kidney disease. Kidney Int 88(2):226\u2013234. https:\/\/doi.org\/10.1038\/ki.2015.115","journal-title":"Kidney Int"},{"issue":"3","key":"3573_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27(3):363\u2013373. https:\/\/doi.org\/10.1007\/s00467-011-1939-1","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3573_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ccc.2015.06.005","volume":"31","author":"SL Kane-Gill","year":"2015","unstructured":"Kane-Gill SL, Goldstein SL (2015) Drug-induced acute kidney injury: a focus on risk assessment for prevention. Crit Care Clin 31(4):675\u2013684. https:\/\/doi.org\/10.1016\/j.ccc.2015.06.005","journal-title":"Crit Care Clin"},{"key":"3573_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000349962","volume":"182","author":"PA McCullough","year":"2013","unstructured":"McCullough PA, Bouchard J, Waikar SS et al (2013) Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:5\u201312. https:\/\/doi.org\/10.1159\/000349962","journal-title":"Contrib Nephrol"},{"issue":"7","key":"3573_CR19","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"issue":"9","key":"3573_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"3573_CR21","unstructured":"Rostom A, Dub\u00e9 C, Cranney A et al (2004) Rockville (MD): Agency for Healthcare Research and Quality (US). Celiac Disease. (Evidence Reports\/Technology Assessments, No. 104.) Appendix D. Quality Assessment Forms. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK35156\/. Accessed 10 Jan 2023"},{"key":"3573_CR22","doi-asserted-by":"publisher","unstructured":"Yang JX, Zhang YY, Yang J (2022) Analysis of the related risk factors in liver and kidney injury and electrolyte disorder induced by cytarabine hydrochloride for injection used in children with tumor. Chin Pharm 25(3):462\u2013467. https:\/\/doi.org\/10.19962\/j.cnki.issn1008-049X.2022.03.014","DOI":"10.19962\/j.cnki.issn1008-049X.2022.03.014"},{"issue":"2","key":"3573_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/npm-210866","volume":"15","author":"Y Al-Jebawi","year":"2022","unstructured":"Al-Jebawi Y, Karalic K, Shekhawat P, Mhanna MJ (2022) The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW). J Neonatal Perinatal Med 15(2):303\u2013309. https:\/\/doi.org\/10.3233\/npm-210866","journal-title":"J Neonatal Perinatal Med"},{"issue":"6","key":"3573_CR24","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s40620-022-01264-6","volume":"35","author":"TH Mohamed","year":"2022","unstructured":"Mohamed TH, Abdi HH, Magers J, Prusakov P, Slaughter JL (2022) Nephrotoxic medications and associated acute kidney injury in hospitalized neonates. J Nephrol 35(6):1679\u20131687. https:\/\/doi.org\/10.1007\/s40620-022-01264-6","journal-title":"J Nephrol"},{"issue":"1","key":"3573_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/ejhpharm-2019-002181","volume":"29","author":"TH Dawoud","year":"2022","unstructured":"Dawoud TH, Khan N, Afzal U, Varghese N, Rahmani A, Abu-Sa\u2019da O (2022) Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates. Eur J Hosp Pharm 29(1):44\u201349. https:\/\/doi.org\/10.1136\/ejhpharm-2019-002181","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"3573_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40199-021-00421-9","volume":"30","author":"S Meysam","year":"2022","unstructured":"Meysam S, Khosravi Z, Rashti R et al (2022) Colistin induced acute kidney injury in critically ill children: a prospective study utilizing RIFLE criteria. Daru 30(1):11\u201315. https:\/\/doi.org\/10.1007\/s40199-021-00421-9","journal-title":"Daru"},{"issue":"9","key":"3573_CR27","doi-asserted-by":"publisher","first-page":"e29738","DOI":"10.1002\/pbc.29738","volume":"69","author":"S Khera","year":"2022","unstructured":"Khera S, Sharma G, Negi V, Shaw SC (2022) Hypoalbuminemia and not undernutrition predicts high-dose methotrexate-induced nephrotoxicity in children with acute lymphoblastic leukemia in resource-constrained centers. Pediatr Blood Cancer 69(9):e29738. https:\/\/doi.org\/10.1002\/pbc.29738","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"3573_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s13312-022-2475-8","volume":"59","author":"M Sravani","year":"2022","unstructured":"Sravani M, Krishnamurthy S, Parameswaran N, Rajappa M (2022) Assessment of causality in hospitalized children With aminoglycoside-related nephrotoxicity. Indian Pediatr 59(3):226\u2013229. https:\/\/doi.org\/10.1007\/s13312-022-2475-8","journal-title":"Indian Pediatr"},{"issue":"23","key":"3573_CR29","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3969\/j.issn.1009-5519.2021.23.022","volume":"37","author":"QY Chen","year":"2021","unstructured":"Chen QY, Wan J, Lin M (2021) Correlation analysis of vancomycin trough concentration and renal toxicity in neonates. J Modern Med Health 37(23):4053\u20134056. https:\/\/doi.org\/10.3969\/j.issn.1009-5519.2021.23.022","journal-title":"J Modern Med Health"},{"key":"3573_CR30","doi-asserted-by":"publisher","unstructured":"Raknoo T, Janjindamai W, Sitaruno S, Dissaneevate S, Ratanajamit C (2021) Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: a 16-year retrospective cohort study. Pharm Pract 19(4):2409. https:\/\/doi.org\/10.18549\/PharmPract.2021.4.2409","DOI":"10.18549\/PharmPract.2021.4.2409"},{"key":"3573_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jpeds.2020.08.035","volume":"228","author":"SN Salerno","year":"2021","unstructured":"Salerno SN, Liao Y, Jackson W et al (2021) Association between nephrotoxic drug combinations and acute kidney injury in the neonatal intensive care unit. J Pediatr 228:213\u2013219. https:\/\/doi.org\/10.1016\/j.jpeds.2020.08.035","journal-title":"J Pediatr"},{"issue":"3","key":"3573_CR32","doi-asserted-by":"publisher","first-page":"e210775","DOI":"10.1001\/jamanetworkopen.2021.0775","volume":"4","author":"L Su","year":"2021","unstructured":"Su L, Li Y, Xu R et al (2021) Association of ibuprofen prescription with acute kidney injury among hospitalized children in China. JAMA Netw Open 4(3):e210775. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0775","journal-title":"JAMA Netw Open"},{"issue":"6","key":"3573_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5863\/1551-6776-26.6.597","volume":"26","author":"H Lu","year":"2021","unstructured":"Lu H, Thurnherr E, Meaney CJ, Fusco NM (2021) Incidence and risk factors for acute kidney injury in hospitalized children receiving piperacillin-tazobactam. J Pediatr Pharmacol Ther 26(6):597\u2013602. https:\/\/doi.org\/10.5863\/1551-6776-26.6.597","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"3573_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.5863\/1551-6776-26.5.467","volume":"26","author":"BS Moffett","year":"2021","unstructured":"Moffett BS, Kulik K, Khichi M, Arikan A (2021) Acetazolamide-associated acute kidney injury in critically ill pediatric patients. J Pediatr Pharmacol Ther 26(5):467\u2013471. https:\/\/doi.org\/10.5863\/1551-6776-26.5.467","journal-title":"J Pediatr Pharmacol Ther"},{"key":"3573_CR35","doi-asserted-by":"publisher","unstructured":"Cen M, Zhao D, Xiong T, Wang Q, Yang GT, Lu Y (2020) Risk Factors for Acute Kidney Injury Induced by Intravenous Infusion of Lianbizhi Injection in Children. J Pediatr Pharm 26(1):23\u201326. https:\/\/doi.org\/10.13407\/j.cnki.jpp.1672-108X.2020.01.008.","DOI":"10.13407\/j.cnki.jpp.1672-108X.2020.01.008"},{"key":"3573_CR36","doi-asserted-by":"publisher","unstructured":"Li Y, Xiong M, Yang M et al (2020) Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children. Ann Transl Med 8(21):1438. https:\/\/doi.org\/10.21037\/atm-20-2284","DOI":"10.21037\/atm-20-2284"},{"issue":"1","key":"3573_CR37","doi-asserted-by":"publisher","first-page":"e6805","DOI":"10.7759\/cureus.6805","volume":"12","author":"R Alqurashi","year":"2020","unstructured":"Alqurashi R, Batwa M, Alghamdi B et al (2020) Acute kidney injury in pediatric patients treated with vancomycin and piperacillin-tazobactam versus vancomycin and cefotaxime: a single-center study. Cureus 12(1):e6805. https:\/\/doi.org\/10.7759\/cureus.6805","journal-title":"Cureus"},{"issue":"2","key":"3573_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00228-019-02781-3","volume":"76","author":"P Gao","year":"2020","unstructured":"Gao P, Guan XL, Huang R et al (2020) Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study. Eur J Clin Pharmacol 76(2):277\u2013284. https:\/\/doi.org\/10.1007\/s00228-019-02781-3","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"3573_CR39","doi-asserted-by":"publisher","first-page":"e203639","DOI":"10.1001\/jamanetworkopen.2020.3639","volume":"3","author":"KR McMahon","year":"2020","unstructured":"McMahon KR, Rassekh SR, Schultz KR et al (2020) Epidemiologic characteristics of acute kidney injury during cisplatin infusions in children treated for cancer. JAMA Netw Open 3(5):e203639. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3639","journal-title":"JAMA Netw Open"},{"key":"3573_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jpeds.2019.12.056","volume":"219","author":"KJ Downes","year":"2020","unstructured":"Downes KJ, Boge CLK, Baro E et al (2020) Acute kidney injury during treatment with intravenous acyclovir for suspected or confirmed neonatal herpes simplex virus infection. J Pediatr 219:126-132.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2019.12.056","journal-title":"J Pediatr"},{"issue":"6","key":"3573_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.5863\/1551-6776-25.6.521","volume":"25","author":"JW Bartlett","year":"2020","unstructured":"Bartlett JW, Gillon J, Hale J, Jimenez-Truque N, Banerjee R (2020) Incidence of acute kidney injury among infants in the neonatal intensive care unit receiving vancomycin with either piperacillin\/tazobactam or cefepime. J Pediatr Pharmacol Ther 25(6):521\u2013527. https:\/\/doi.org\/10.5863\/1551-6776-25.6.521","journal-title":"J Pediatr Pharmacol Ther"},{"key":"3573_CR42","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.2147\/idr.S272982","volume":"13","author":"D Sun","year":"2020","unstructured":"Sun D, Zhang T, Mi J et al (2020) Therapeutic drug monitoring and nephrotoxicity of teicoplanin therapy in Chinese children: a retrospective study. Infect Drug Resist 13:4105\u20134113. https:\/\/doi.org\/10.2147\/idr.S272982","journal-title":"Infect Drug Resist"},{"key":"3573_CR43","doi-asserted-by":"publisher","unstructured":"Lu JY, Shi K (2019) Proton pump inhibitors on acute kidney injury in children. J Pediatr Pharm 25(12):40\u201343. https:\/\/doi.org\/10.13407\/j.cnki.jpp.1672-108X.2019.12.013","DOI":"10.13407\/j.cnki.jpp.1672-108X.2019.12.013"},{"key":"3573_CR44","doi-asserted-by":"publisher","unstructured":"Dai XM (2019) The effect of furosemide on acute kidney injury and mortality in critically ill children with fluid overload. https:\/\/doi.org\/10.27351\/d.cnki.gszhu.2019.002720","DOI":"10.27351\/d.cnki.gszhu.2019.002720"},{"issue":"3","key":"3573_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jcpt.12806","volume":"44","author":"T Zhang","year":"2019","unstructured":"Zhang T, Cheng H, Li Y et al (2019) Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem. J Clin Pharm Ther 44(3):440\u2013446. https:\/\/doi.org\/10.1111\/jcpt.12806","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"3573_CR46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jpids\/piy030","volume":"8","author":"KM Cook","year":"2019","unstructured":"Cook KM, Gillon J, Grisso AG et al (2019) Incidence of nephrotoxicity among pediatric patients receiving vancomycin with either piperacillin-tazobactam or cefepime: a cohort study. J Pediatric Infect Dis Soc 8(3):221\u2013227. https:\/\/doi.org\/10.1093\/jpids\/piy030","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"16","key":"3573_CR47","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/ajhp\/zxz125","volume":"76","author":"KM Buhlinger","year":"2019","unstructured":"Buhlinger KM, Fuller KA, Faircloth CB, Wallace JR (2019) Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients. Am J Health Syst Pharm 76(16):1204\u20131210. https:\/\/doi.org\/10.1093\/ajhp\/zxz125","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"3573_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40272-019-00328-8","volume":"21","author":"JC Fitzgerald","year":"2019","unstructured":"Fitzgerald JC, Zane NR, Himebauch AS et al (2019) Vancomycin prescribing and therapeutic drug monitoring in children with and without acute kidney injury after cardiac arrest. Paediatr Drugs 21(2):107\u2013112. https:\/\/doi.org\/10.1007\/s40272-019-00328-8","journal-title":"Paediatr Drugs"},{"issue":"7","key":"3573_CR49","doi-asserted-by":"publisher","first-page":"e27750","DOI":"10.1002\/pbc.27750","volume":"66","author":"HT Quach","year":"2019","unstructured":"Quach HT, Esbenshade AJ, Zhao Z, Banerjee R (2019) Incidence of acute kidney injury among pediatric hematology\/oncology patients receiving vancomycin in combination with piperacillin\/tazobactam or cefepime. Pediatr Blood Cancer 66(7):e27750. https:\/\/doi.org\/10.1002\/pbc.27750","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"3573_CR50","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/inf.0000000000002391","volume":"38","author":"HDS Feiten","year":"2019","unstructured":"Feiten HDS, Okumura LM, Martinbiancho JK et al (2019) Vancomycin-associated nephrotoxicity and risk factors in critically ill children without preexisting renal injury. Pediatr Infect Dis J 38(9):934\u2013938. https:\/\/doi.org\/10.1097\/inf.0000000000002391","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"3573_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3760\/cma.j.issn.1008-5734.2018.02.002","volume":"20","author":"XJ Shen","year":"2018","unstructured":"Shen XJ, Zeng JW, Wu HY, Chen J, Chen X (2018) Analysis of occurrence and risk factors of vancomycin-associated acute kidney injury in patients in the pediatric intensive care unit. Adverse Drug React 20(2):83\u201390. https:\/\/doi.org\/10.3760\/cma.j.issn.1008-5734.2018.02.002","journal-title":"Adverse Drug React"},{"key":"3573_CR52","doi-asserted-by":"publisher","first-page":"9256528","DOI":"10.1155\/2018\/9256528","volume":"2018","author":"M Al Nuhait","year":"2018","unstructured":"Al Nuhait M, Abu Esba LC, Al Harbi K, Al Meshary M, Bustami RT (2018) Acute kidney injury in pediatric treated with vancomycin and piperacillin-tazobactam in tertiary care hospital. Int J Pediatr 2018:9256528. https:\/\/doi.org\/10.1155\/2018\/9256528","journal-title":"Int J Pediatr"},{"issue":"2","key":"3573_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/ped.13463","volume":"60","author":"M Abouelkheir","year":"2018","unstructured":"Abouelkheir M, Alsubaie S (2018) Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam. Pediatr Int 60(2):136\u2013141. https:\/\/doi.org\/10.1111\/ped.13463","journal-title":"Pediatr Int"},{"issue":"1","key":"3573_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/8755122517747088","volume":"34","author":"H Woldu","year":"2018","unstructured":"Woldu H, Guglielmo BJ (2018) Incidence and risk factors for vancomycin nephrotoxicity in acutely ill pediatric patients. J Pharm Technol 34(1):9\u201316. https:\/\/doi.org\/10.1177\/8755122517747088","journal-title":"J Pharm Technol"},{"issue":"7","key":"3573_CR55","doi-asserted-by":"publisher","first-page":"e27038","DOI":"10.1002\/pbc.27038","volume":"65","author":"D Barnoud","year":"2018","unstructured":"Barnoud D, Pin\u00e7on C, Bruno B et al (2018) Acute kidney injury after high dose etoposide phosphate: a retrospective study in children receiving an allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 65(7):e27038. https:\/\/doi.org\/10.1002\/pbc.27038","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"3573_CR56","doi-asserted-by":"publisher","first-page":"e0202439","DOI":"10.1371\/journal.pone.0202439","volume":"13","author":"BS Moffett","year":"2018","unstructured":"Moffett BS, Morris J, Kam C, Galati M, Dutta A, Akcan-Arikan A (2018) Vancomycin associated acute kidney injury in pediatric patients. PLoS ONE 13(10):e0202439. https:\/\/doi.org\/10.1371\/journal.pone.0202439","journal-title":"PLoS ONE"},{"issue":"1","key":"3573_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12887-017-0777-0","volume":"17","author":"V Bhargava","year":"2017","unstructured":"Bhargava V, Malloy M, Fonseca R (2017) The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit. BMC Pediatr 17(1):50. https:\/\/doi.org\/10.1186\/s12887-017-0777-0","journal-title":"BMC Pediatr"},{"issue":"12","key":"3573_CR58","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1097\/pcc.0000000000001335","volume":"18","author":"MR Holsen","year":"2017","unstructured":"Holsen MR, Meaney CJ, Hassinger AB, Fusco NM (2017) Increased risk of acute kidney injury in critically ill children treated with vancomycin and piperacillin\/tazobactam. Pediatr Crit Care Med 18(12):e585\u2013e591. https:\/\/doi.org\/10.1097\/pcc.0000000000001335","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"3573_CR59","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ppul.23718","volume":"52","author":"LK LeCleir","year":"2017","unstructured":"LeCleir LK, Pettit RS (2017) Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients. Pediatr Pulmonol 52(8):1000\u20131005. https:\/\/doi.org\/10.1002\/ppul.23718","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"3573_CR60","doi-asserted-by":"publisher","first-page":"e173219","DOI":"10.1001\/jamapediatrics.2017.3219","volume":"171","author":"KJ Downes","year":"2017","unstructured":"Downes KJ, Cowden C, Laskin BL et al (2017) Association of acute kidney injury with concomitant vancomycin and piperacillin\/tazobactam treatment among hospitalized children. JAMA Pediatr 171(12):e173219. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.3219","journal-title":"JAMA Pediatr"},{"issue":"10","key":"3573_CR61","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/jp.2017.80","volume":"37","author":"JE Constance","year":"2017","unstructured":"Constance JE, Reith D, Ward RM et al (2017) Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. J Perinatol 37(10):1093\u20131102. https:\/\/doi.org\/10.1038\/jp.2017.80","journal-title":"J Perinatol"},{"issue":"1","key":"3573_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00467-016-3471-9","volume":"32","author":"JA Saban","year":"2017","unstructured":"Saban JA, Pizzi M, Caldwell J, Palijan A, Zappitelli M (2017) Previous aminoglycoside use and acute kidney injury risk in non-critically ill children. Pediatr Nephrol 32(1):173\u2013179. https:\/\/doi.org\/10.1007\/s00467-016-3471-9","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"3573_CR63","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13054-017-1899-3","volume":"21","author":"G Hundeshagen","year":"2017","unstructured":"Hundeshagen G, Herndon DN, Capek KD et al (2017) Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients. Crit Care 21(1):318. https:\/\/doi.org\/10.1186\/s13054-017-1899-3","journal-title":"Crit Care"},{"issue":"1","key":"3573_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5428\/pcar20160109","volume":"16","author":"ZL Li","year":"2016","unstructured":"Li ZL, Xv F, Hu WJ, Xiao ZJ, Liu HX, Li J (2016) Comparison of the nephrotoxicity of low trough concentration and high trough concentration of vancomycin in neonates. Pharm Care Res 16(1):29\u201333. https:\/\/doi.org\/10.5428\/pcar20160109","journal-title":"Pharm Care Res"},{"issue":"6","key":"3573_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.5863\/1551-6776-21.6.486","volume":"21","author":"S Bonazza","year":"2016","unstructured":"Bonazza S, Bresee LC, Kraft T, Ross BC, Dersch-Mills D (2016) Frequency of and risk factors for acute kidney injury associated with vancomycin use in the pediatric intensive care unit. J Pediatr Pharmacol Ther 21(6):486\u2013493. https:\/\/doi.org\/10.5863\/1551-6776-21.6.486","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"3573_CR66","doi-asserted-by":"publisher","first-page":"F236","DOI":"10.1136\/archdischild-2015-308459","volume":"101","author":"JE Constance","year":"2016","unstructured":"Constance JE, Balch AH, Stockmann C et al (2016) A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates. Arch Dis Child Fetal Neonatal Ed 101(3):F236\u2013F243. https:\/\/doi.org\/10.1136\/archdischild-2015-308459","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"3573_CR67","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/mph.0000000000000470","volume":"38","author":"GT Seixas","year":"2016","unstructured":"Seixas GT, Araujo OR, Silva DC, Arduini RG, Petrilli AS (2016) Vancomycin therapeutic targets and nephrotoxicity in critically ill children with cancer. J Pediatr Hematol Oncol 38(2):e56\u2013e62. https:\/\/doi.org\/10.1097\/mph.0000000000000470","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"3573_CR68","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3969\/j.issn.1672-8467.2015.06.009","volume":"42","author":"X Gao","year":"2015","unstructured":"Gao X, Li J, Li ZP (2015) Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized children with or without concomitant piperacillin-tazobactam. Fudan Univ J Med Sci 42(6):743\u2013748. https:\/\/doi.org\/10.3969\/j.issn.1672-8467.2015.06.009","journal-title":"Fudan Univ J Med Sci"},{"issue":"11","key":"3573_CR69","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3971\/j.issn.1000-8578.2015.11.020","volume":"42","author":"DH Cheng","year":"2015","unstructured":"Cheng DH, Lu H, Huang ZG, Qin XK (2015) Influence of drug combinations on high-dose methotrexate-induced nephrotoxicity and blood concentrations of childhood acute lymphoblastic leukemia. Cancer Res Prev Treat 42(11):1148\u20131151. https:\/\/doi.org\/10.3971\/j.issn.1000-8578.2015.11.020","journal-title":"Cancer Res Prev Treat"},{"issue":"5","key":"3573_CR70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40261-015-0287-5","volume":"35","author":"Y Lim","year":"2015","unstructured":"Lim Y, Lyall H, Foster C (2015) Tenofovir-associated nephrotoxicity in children with perinatally-acquired HIV infection: a single-centre cohort study. Clin Drug Investig 35(5):327\u2013333. https:\/\/doi.org\/10.1007\/s40261-015-0287-5","journal-title":"Clin Drug Investig"},{"issue":"3","key":"3573_CR71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/phar.1552","volume":"35","author":"KL Matson","year":"2015","unstructured":"Matson KL, Shaffer CL, Beck GL, Simonsen KA (2015) Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Pharmacotherapy 35(3):337\u2013343. https:\/\/doi.org\/10.1002\/phar.1552","journal-title":"Pharmacotherapy"},{"issue":"10","key":"3573_CR72","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/1060028015594190","volume":"49","author":"CA Knoderer","year":"2015","unstructured":"Knoderer CA, Gritzman AL, Nichols KR, Wilson AC (2015) Late-occurring vancomycin-associated acute kidney injury in children receiving prolonged therapy. Ann Pharmacother 49(10):1113\u20131119. https:\/\/doi.org\/10.1177\/1060028015594190","journal-title":"Ann Pharmacother"},{"issue":"34","key":"3573_CR73","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1097\/MD.0000000000001413","volume":"94","author":"CA Jim\u00e9nez-Triana","year":"2015","unstructured":"Jim\u00e9nez-Triana CA, Castel\u00e1n-Mart\u00ednez OD, Rivas-Ruiz R et al (2015) Cisplatin nephrotoxicity and longitudinal growth in children with solid tumors. Medicine 94(34):e1413. https:\/\/doi.org\/10.1097\/MD.0000000000001413","journal-title":"Medicine"},{"issue":"1","key":"3573_CR74","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1111\/chd.12187","volume":"10","author":"BS Moffett","year":"2015","unstructured":"Moffett BS, Hilvers PS, Dinh K, Arikan AA, Checchia P, Bronicki R (2015) Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients. Congenit Heart Dis 10(1):E6\u2013E10. https:\/\/doi.org\/10.1111\/chd.12187","journal-title":"Congenit Heart Dis"},{"issue":"10","key":"3573_CR75","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00467-015-3105-7","volume":"30","author":"A Balestracci","year":"2015","unstructured":"Balestracci A, Ezquer M, Elmo ME et al (2015) Ibuprofen-associated acute kidney injury in dehydrated children with acute gastroenteritis. Pediatr Nephrol 30(10):1873\u20131878. https:\/\/doi.org\/10.1007\/s00467-015-3105-7","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"3573_CR76","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00246-013-0813-2","volume":"35","author":"KA Lindle","year":"2014","unstructured":"Lindle KA, Dinh K, Moffett BS et al (2014) Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease. Pediatr Cardiol 35(3):499\u2013506. https:\/\/doi.org\/10.1007\/s00246-013-0813-2","journal-title":"Pediatr Cardiol"},{"issue":"12","key":"3573_CR77","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1177\/1060028014549185","volume":"48","author":"EA Sinclair","year":"2014","unstructured":"Sinclair EA, Yenokyan G, McMunn A, Fadrowski JJ, Milstone AM, Lee CK (2014) Factors associated with acute kidney injury in children receiving vancomycin. Ann Pharmacother 48(12):1555\u20131562. https:\/\/doi.org\/10.1177\/1060028014549185","journal-title":"Ann Pharmacother"},{"issue":"2","key":"3573_CR78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/jpids\/pit076","volume":"3","author":"CA Knoderer","year":"2014","unstructured":"Knoderer CA, Nichols KR, Lyon KC, Veverka MM, Wilson AC (2014) Are elevated vancomycin serum trough concentrations achieved within the first 7 days of therapy associated with acute kidney injury in children? J Pediatric Infect Dis Soc 3(2):127\u2013131. https:\/\/doi.org\/10.1093\/jpids\/pit076","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"3573_CR79","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1542\/peds.2013-0794","volume":"132","author":"SL Goldstein","year":"2013","unstructured":"Goldstein SL, Kirkendall E, Nguyen H et al (2013) Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 132(3):e756\u2013e767. https:\/\/doi.org\/10.1542\/peds.2013-0794","journal-title":"Pediatrics"},{"issue":"6","key":"3573_CR80","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jpeds.2012.11.069","volume":"162","author":"JM Misurac","year":"2013","unstructured":"Misurac JM, Knoderer CA, Leiser JD, Nailescu C, Wilson AC, Andreoli SP (2013) Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. J Pediatr 162(6):1153-1159.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2012.11.069","journal-title":"J Pediatr"},{"issue":"6","key":"3573_CR81","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/phar.1259","volume":"33","author":"BR Totapally","year":"2013","unstructured":"Totapally BR, Machado J, Lee H, Paredes A, Raszynski A (2013) Acute kidney injury during vancomycin therapy in critically ill children. Pharmacotherapy 33(6):598\u2013602. https:\/\/doi.org\/10.1002\/phar.1259","journal-title":"Pharmacotherapy"},{"issue":"1","key":"3573_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40121-013-0004-8","volume":"2","author":"AR Ragab","year":"2013","unstructured":"Ragab AR, Al-Mazroua MK, Al-Harony MA (2013) Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children. Infect Dis Ther 2(1):37\u201346. https:\/\/doi.org\/10.1007\/s40121-013-0004-8","journal-title":"Infect Dis Ther"},{"issue":"1","key":"3573_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00246-011-0046-1","volume":"33","author":"CM Phelps","year":"2012","unstructured":"Phelps CM, Eshelman J, Cruz ED et al (2012) Acute kidney injury after cardiac surgery in infants and children: evaluation of the role of angiotensin-converting enzyme inhibitors. Pediatr Cardiol 33(1):1\u20137. https:\/\/doi.org\/10.1007\/s00246-011-0046-1","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"3573_CR84","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ndt\/gfq375","volume":"26","author":"M Zappitelli","year":"2011","unstructured":"Zappitelli M, Moffett BS, Hyder A et al (2011) Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 26(1):144\u2013150. https:\/\/doi.org\/10.1093\/ndt\/gfq375","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3573_CR85","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/jclinpath-2011-200005","volume":"64","author":"JH Kim","year":"2011","unstructured":"Kim JH, Park SJ, Yoon SJ et al (2011) Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome. J Clin Pathol 64(6):516\u2013519. https:\/\/doi.org\/10.1136\/jclinpath-2011-200005","journal-title":"J Clin Pathol"},{"issue":"5","key":"3573_CR86","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/PCC.0b013e31820ac40a","volume":"12","author":"BS Moffett","year":"2011","unstructured":"Moffett BS, Goldstein SL, Adusei M, Kuzin J, Mohan P, Mott AR (2011) Risk factors for postoperative acute kidney injury in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. Pediatr Crit Care Med 12(5):555\u2013559. https:\/\/doi.org\/10.1097\/PCC.0b013e31820ac40a","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"3573_CR87","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/pbc.20858","volume":"48","author":"W St\u00f6hr","year":"2007","unstructured":"St\u00f6hr W, Paulides M, Bielack S et al (2007) Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 48(4):447\u2013452. https:\/\/doi.org\/10.1002\/pbc.20858","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"3573_CR88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pbc.20011","volume":"42","author":"JS McCune","year":"2004","unstructured":"McCune JS, Friedman DL, Schuetze S, Blough D, Magbulos M, Hawkins DS (2004) Influence of age upon Ifosfamide-induced nephrotoxicity. Pediatr Blood Cancer 42(5):427\u2013432. https:\/\/doi.org\/10.1002\/pbc.20011","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"3573_CR89","first-page":"28","volume":"9","author":"FZ Yang","year":"2002","unstructured":"Yang FZ, Xv CH, Zhong RL (2002) Mannitol induced renal function impairment in children: a report of 267 cases. Chin Pediatr Emerg Med 9(1):28","journal-title":"Chin Pediatr Emerg Med"},{"issue":"4","key":"3573_CR90","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1542\/peds.103.4.e48","volume":"103","author":"V Bhatt-Mehta","year":"1999","unstructured":"Bhatt-Mehta V, Schumacher RE, Faix RG, Leady M, Brenner T (1999) Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study. Pediatrics 103(4):e48. https:\/\/doi.org\/10.1542\/peds.103.4.e48","journal-title":"Pediatrics"},{"issue":"11","key":"3573_CR91","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/ijms17111826","volume":"17","author":"K Hosohata","year":"2016","unstructured":"Hosohata K (2016) Role of oxidative stress in drug-induced kidney injury. Int J Mol Sci 17(11):1826. https:\/\/doi.org\/10.3390\/ijms17111826","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3573_CR92","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/ki.2010.475","volume":"81","author":"MA Perazella","year":"2012","unstructured":"Perazella MA (2012) Drug use and nephrotoxicity in the intensive care unit. Kidney Int 81(12):1172\u20131178. https:\/\/doi.org\/10.1038\/ki.2010.475","journal-title":"Kidney Int"},{"issue":"2","key":"3573_CR93","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1542\/pir.23-2-47","volume":"23","author":"JC Chan","year":"2002","unstructured":"Chan JC, Williams DM, Roth KS (2002) Kidney failure in infants and children. Pediatr Rev 23(2):47\u201360. https:\/\/doi.org\/10.1542\/pir.23-2-47","journal-title":"Pediatr Rev"},{"issue":"1","key":"3573_CR94","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/CCM.0b013e3181bfb0b5","volume":"38","author":"P Dennen","year":"2010","unstructured":"Dennen P, Douglas IS, Anderson R (2010) Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med 38(1):261\u2013275. https:\/\/doi.org\/10.1097\/CCM.0b013e3181bfb0b5","journal-title":"Crit Care Med"},{"issue":"3","key":"3573_CR95","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/cc5949","volume":"11","author":"SM Bagshaw","year":"2007","unstructured":"Bagshaw SM, George C, Bellomo R (2007) Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 11(3):R68. https:\/\/doi.org\/10.1186\/cc5949","journal-title":"Crit Care"},{"issue":"7","key":"3573_CR96","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1097\/01.Ccm.0000224227.70642.4f","volume":"34","author":"S Uchino","year":"2006","unstructured":"Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C (2006) An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 34(7):1913\u20131917. https:\/\/doi.org\/10.1097\/01.Ccm.0000224227.70642.4f","journal-title":"Crit Care Med"},{"issue":"6","key":"3573_CR97","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.ccx.0000247448.94252.5a","volume":"12","author":"S Uchino","year":"2006","unstructured":"Uchino S (2006) The epidemiology of acute renal failure in the world. Curr Opin Crit Care 12(6):538\u2013543. https:\/\/doi.org\/10.1097\/01.ccx.0000247448.94252.5a","journal-title":"Curr Opin Crit Care"},{"issue":"11","key":"3573_CR98","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3969\/j.issn.1673-5390.2021.11.010","volume":"214","author":"YC Yu","year":"2021","unstructured":"Yu YC, Peng XX, Nie XL et al (2021) Application of real-world data in the monitoring of drug-induced renal injury in children: progress and strategies. Chin Food Drug Admin Mag 214(11):83\u201387. https:\/\/doi.org\/10.3969\/j.issn.1673-5390.2021.11.010","journal-title":"Chin Food Drug Admin Mag"},{"issue":"09","key":"3573_CR99","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.6039\/j.issn.1001-0408.2021.09.13","volume":"32","author":"KM Pan","year":"2021","unstructured":"Pan KM, Chen C, Jiang Y et al (2021) Systematic review of drug-induced acute kidney injury in Chinese population. Chin Pharm 32(09):1100\u20131107. https:\/\/doi.org\/10.6039\/j.issn.1001-0408.2021.09.13","journal-title":"Chin Pharm"},{"key":"3573_CR100","doi-asserted-by":"publisher","unstructured":"Che ML, Yan YC, Zhang Y et al (2009) Analysis of drug-induced acute renal failure in Shanghai. 89(11):744\u2013749. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2009.11.007","DOI":"10.3760\/cma.j.issn.0376-2491.2009.11.007"},{"key":"3573_CR101","first-page":"387","volume":"7","author":"JY Yang","year":"2005","unstructured":"Yang JY (2005) Drug-induced kidney injury. Chin J Pract Pediatr 7:387\u2013390","journal-title":"Chin J Pract Pediatr"},{"issue":"8","key":"3573_CR102","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","volume":"17","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Rosner MH (2022) Drug-Induced Acute Kidney Injury. Clin J Am Soc Nephrol 17(8):1220\u20131233. https:\/\/doi.org\/10.2215\/CJN.11290821","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"3573_CR103","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/archdischild-2021-323429","volume":"107","author":"C Williams","year":"2022","unstructured":"Williams C, Hankinson C, McWilliam SJ, Oni L (2022) Vancomycin-associated acute kidney injury epidemiology in children: a systematic review. Arch Dis Child 107(10):947\u2013954. https:\/\/doi.org\/10.1136\/archdischild-2021-323429","journal-title":"Arch Dis Child"},{"issue":"11","key":"3573_CR104","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s12630-010-9375-4","volume":"57","author":"SM Bagshaw","year":"2010","unstructured":"Bagshaw SM, Bellomo R, Devarajan P et al (2010) Review article: Acute kidney injury in critical illness. Can J Anaesth 57(11):985\u2013998. https:\/\/doi.org\/10.1007\/s12630-010-9375-4","journal-title":"Can J Anaesth"},{"issue":"5","key":"3573_CR105","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00467-009-1133-x","volume":"24","author":"DJ Askenazi","year":"2009","unstructured":"Askenazi DJ, Griffin R, McGwin G, Carlo W, Ambalavanan N (2009) Acute kidney injury is independently associated with mortality in very low birthweight infants: a matched case-control analysis. Pediatr Nephrol 24(5):991\u2013997. https:\/\/doi.org\/10.1007\/s00467-009-1133-x","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3573_CR106","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00467-008-1074-9","volume":"24","author":"SP Andreoli","year":"2009","unstructured":"Andreoli SP (2009) Acute kidney injury in children. Pediatr Nephrol 24(2):253\u2013263. https:\/\/doi.org\/10.1007\/s00467-008-1074-9","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"3573_CR107","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.ajkd.2004.09.028","volume":"45","author":"S Hui-Stickle","year":"2005","unstructured":"Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45(1):96\u2013101. https:\/\/doi.org\/10.1053\/j.ajkd.2004.09.028","journal-title":"Am J Kidney Dis"},{"issue":"1\u20133","key":"3573_CR108","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000334143","volume":"33","author":"SL Goldstein","year":"2012","unstructured":"Goldstein SL (2012) Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 33(1\u20133):131\u2013137. https:\/\/doi.org\/10.1159\/000334143","journal-title":"Blood Purif"},{"issue":"1","key":"3573_CR109","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.kint.2016.03.031","volume":"90","author":"SL Goldstein","year":"2016","unstructured":"Goldstein SL, Mottes T, Simpson K et al (2016) A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 90(1):212\u2013221. https:\/\/doi.org\/10.1016\/j.kint.2016.03.031","journal-title":"Kidney Int"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03573-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T20:05:38Z","timestamp":1700597138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03573-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":109,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3573"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03573-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}